Aquavit Files Two IND’s For Its Botulinum Toxin With FDA

Announces its IND Submissions to FDA for Aquatox™ at the Annual American Academy of Dermatology 2023 NEW YORK, March 17, 2023 /PRNewswire/ — Aquavit Holdings, the exclusive licensee of Huons Global’s Botulinum Toxin in the USA and Canada, will officially unveil the Aquatox™ program at…

Leave a Reply

Your email address will not be published. Required fields are marked *